Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1061 | 1025 | 1132 | 1242 | 1551 | 2936 |
Fund Return | 6.14% | 2.46% | 13.15% | 7.49% | 9.17% | 11.37% |
Place in category | 1142 | 1590 | 943 | 284 | 313 | 40 |
% in Category | 64 | 90 | 59 | 24 | 28 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth CAD | 4.1B | 5.68 | 6.11 | 9.92 | ||
Renaissance International Eq CAD | 1.76B | 3.26 | 1.77 | 6.65 | ||
Renaissance International Eq Cl CAD | 1.76B | 3.71 | 3.10 | 8.10 | ||
Renaissance US Equity Income F CAD | 1.39B | 6.77 | 7.73 | 10.34 | ||
Renaissance US Eq Income F Pr CAD | 1.39B | 6.79 | 7.79 | 10.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 12.83B | 23.15 | 9.70 | - | ||
Mawer Global Equity | 12.7B | 3.94 | 7.52 | 10.88 | ||
Capital Group Glbal Equity Fd A CAD | 12.7B | 10.93 | 1.65 | 9.88 | ||
Capital Group Glbal Equity Fd D CAD | 12.7B | 11.21 | 2.42 | 10.61 | ||
Capital Group Glbal Equity Fd F CAD | 12.7B | 11.34 | 2.77 | 11.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.33 | 912.9 | -0.46% | |
Microsoft | US5949181045 | 4.04 | 420.99 | -0.49% | |
Mastercard | US57636Q1040 | 3.04 | 458.87 | +0.19% | |
Amphenol | US0320951017 | 2.83 | 131.71 | -0.19% | |
Linde PLC | IE000S9YS762 | 2.82 | 395.600 | -0.45% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review